Champions Oncology, Inc. (CSBR)
USD 8.3
(-0.12%)
USD 8.3
(-0.12%)
| Breakdown | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | -6.13 Million | 3.95 Million | 6.49 Million | -1.68 Million | 2.9 Million | 1.86 Million |
| Net Income | -7.27 Million | -5.33 Million | 548 Thousand | 334 Thousand | -1.97 Million | 128 Thousand |
| Depreciation & Amortization | 1.86 Million | 2.24 Million | 1.62 Million | 1.18 Million | 825 Thousand | 606 Thousand |
| Deferred income taxes | - | 1 Million | - | 49 Thousand | 560 Thousand | 71 Thousand |
| Stock-based compensation | 1.11 Million | 864 Thousand | 912 Thousand | 598 Thousand | 600 Thousand | 636 Thousand |
| Change in working capital | -3.82 Million | 4.22 Million | 2.33 Million | -4.16 Million | 2.49 Million | 11 Thousand |
| Other non-cash items | 8.35 Million | 952 Thousand | 1.07 Million | 323 Thousand | 403 Thousand | 410 Thousand |
| Investing Cash Flow | -836 Thousand | -2.87 Million | -2.38 Million | -3.16 Million | -2.22 Million | -834 Thousand |
| Investments in PPE | -836 Thousand | -2.87 Million | -2.38 Million | -3.28 Million | -2.22 Million | -834 Thousand |
| Acquisitions | - | - | - | - | - | - |
| Investment purchases | - | - | - | - | - | - |
| Sales/Maturities of investments | - | - | - | - | - | - |
| Other Investing Activities | - | - | - | 112 Thousand | - | - |
| Financing Cash Flow | -527 Thousand | 11 Thousand | 207 Thousand | 1.19 Million | 4.42 Million | 1.2 Million |
| Debt repayment | -146 Thousand | - | - | -174 Thousand | -35 Thousand | -262 Thousand |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | -634 Thousand | -74 Thousand | - | - | - | - |
| Common Stock Issuance | 253 Thousand | 85 Thousand | 207 Thousand | 1.36 Million | 4.45 Million | 6000.00 |
| Other Financing Activities | 107 Thousand | 11 Thousand | 207 Thousand | 1.19 Million | 4.42 Million | 1.45 Million |
| Accounts receivables | -1.99 Million | 1.3 Million | -2.81 Million | -2.26 Million | -670 Thousand | -531 Thousand |
| Accounts payables | 465 Thousand | 2.46 Million | 974 Thousand | -1.24 Million | 333 Thousand | 653 Thousand |
| Inventory | - | - | - | -1.09 Million | 1.03 Million | 571 Thousand |
| Other working capital | -2.29 Million | -3.77 Million | 4.18 Million | 441 Thousand | 1.79 Million | -682 Thousand |
| Cash at beginning of period | 10.11 Million | 9 Million | 4.68 Million | 8.34 Million | 3.23 Million | 1 Million |
| Cash at end of period | 2.61 Million | 10.1 Million | 9 Million | 4.68 Million | 8.34 Million | 3.23 Million |
| Capital Expenditure | -836 Thousand | -2.87 Million | -2.38 Million | -3.28 Million | -2.22 Million | -834 Thousand |
| Effect of forex changes on cash | - | 17 Thousand | - | - | - | - |
| Net cash flow / Change in cash | -7.5 Million | 1.09 Million | 4.32 Million | -3.65 Million | 5.1 Million | 2.23 Million |
| Free Cash Flow | -6.97 Million | 1.08 Million | 4.11 Million | -4.96 Million | 685 Thousand | 1.02 Million |
| Breakdown | 2024 Q4 | 2024 FY | 2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 Q4 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | -109 Thousand | -7.27 Million | -2.53 Million | -2.07 Million | -2.56 Million | -2.56 Million |
| Depreciation & Amortization | 457 Thousand | 1.86 Million | 1.26 Million | 484 Thousand | 445 Thousand | 583 Thousand |
| Deferred income taxes | 1.04 Million | - | -1.34 Million | 137 Thousand | 162 Thousand | 919 Thousand |
| Stock-based compensation | 263 Thousand | 1.11 Million | 379 Thousand | 53 Thousand | 423 Thousand | 208 Thousand |
| Change in working capital | -3.22 Million | -3.82 Million | 375 Thousand | 1.75 Million | -2.72 Million | 7000.00 |
| Other non-cash items | 2.72 Million | 8.35 Million | 935 Thousand | 232 Thousand | 270 Thousand | 135 Thousand |
| Investing Cash Flow | 111 Thousand | -836 Thousand | -126 Thousand | -153 Thousand | -668 Thousand | -760 Thousand |
| Investments in PPE | 111 Thousand | -836 Thousand | -126 Thousand | -153 Thousand | -668 Thousand | -760 Thousand |
| Acquisitions | - | - | - | - | - | - |
| Investment purchases | - | - | - | - | - | - |
| Sales/Maturities of investments | - | - | - | - | - | - |
| Other Investing Activities | - | - | - | - | - | - |
| Financing Cash Flow | -145 Thousand | -527 Thousand | - | 208 Thousand | -590 Thousand | -75 Thousand |
| Debt repayment | -146 Thousand | -146 Thousand | - | - | - | - |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | -634 Thousand | - | -32 Thousand | -602 Thousand | -74 Thousand |
| Common Stock Issuance | 1000.00 | 253 Thousand | - | 240 Thousand | 12 Thousand | -1000.00 |
| Other Financing Activities | -145 Thousand | 107 Thousand | - | 240 Thousand | -590 Thousand | -75 Thousand |
| Accounts receivables | -1.79 Million | -1.99 Million | -250 Thousand | 1.15 Million | -1.09 Million | -69 Thousand |
| Accounts payables | 1.04 Million | 465 Thousand | 222 Thousand | -1.22 Million | 424 Thousand | 1.03 Million |
| Inventory | 415 Thousand | - | - | 1000.00 | -416 Thousand | -3.77 Million |
| Other working capital | -2.47 Million | -2.29 Million | 403 Thousand | 1.82 Million | -1.63 Million | 2.81 Million |
| Cash at beginning of period | 4.46 Million | 10.11 Million | 5.51 Million | 4.86 Million | 10.11 Million | 11.64 Million |
| Cash at end of period | 2.61 Million | 2.61 Million | 4.46 Million | 5.51 Million | 4.86 Million | 10.1 Million |
| Capital Expenditure | 111 Thousand | -836 Thousand | -126 Thousand | -153 Thousand | -668 Thousand | -760 Thousand |
| Effect of forex changes on cash | - | - | - | - | - | 17 Thousand |
| Net cash flow / Change in cash | -1.85 Million | -7.5 Million | -1.04 Million | 644 Thousand | -5.24 Million | -1.54 Million |
| Free Cash Flow | -1.7 Million | -6.97 Million | -1.04 Million | 436 Thousand | -4.65 Million | -1.46 Million |
7701
ACR
5388
MCDS
3580
VOLLF